MA37749B1 - Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine - Google Patents
Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équineInfo
- Publication number
- MA37749B1 MA37749B1 MA37749A MA37749A MA37749B1 MA 37749 B1 MA37749 B1 MA 37749B1 MA 37749 A MA37749 A MA 37749A MA 37749 A MA37749 A MA 37749A MA 37749 B1 MA37749 B1 MA 37749B1
- Authority
- MA
- Morocco
- Prior art keywords
- african horse
- horse sickness
- bluetongue
- vaccines against
- sickness virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12111—Orbivirus, e.g. bluetongue virus
- C12N2720/12171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des vaccins ou des compositions contre la fièvre catarrhale (btv) et la peste équine (ashv), des procédés de production de vecteurs recombinés des virus réassortis de la fièvre catarrhale et de la peste équine, et des procédés de vaccination contre la fièvre catarrhale et la peste équine.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261659198P | 2012-06-13 | 2012-06-13 | |
PCT/US2013/045667 WO2013188673A2 (fr) | 2012-06-13 | 2013-06-13 | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine |
Publications (2)
Publication Number | Publication Date |
---|---|
MA37749A1 MA37749A1 (fr) | 2016-08-31 |
MA37749B1 true MA37749B1 (fr) | 2017-05-31 |
Family
ID=49237584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA37749A MA37749B1 (fr) | 2012-06-13 | 2013-06-13 | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine |
Country Status (18)
Country | Link |
---|---|
US (1) | US10801039B2 (fr) |
EP (1) | EP2861248B1 (fr) |
JP (1) | JP6347257B2 (fr) |
KR (1) | KR102136437B1 (fr) |
CN (2) | CN104582724A (fr) |
AU (2) | AU2013274191B2 (fr) |
BR (1) | BR112014031133B1 (fr) |
CA (1) | CA2876196C (fr) |
ES (1) | ES2664069T3 (fr) |
HK (1) | HK1209326A1 (fr) |
IL (1) | IL236148B (fr) |
MA (1) | MA37749B1 (fr) |
MX (1) | MX364875B (fr) |
NZ (1) | NZ703297A (fr) |
RU (1) | RU2656187C2 (fr) |
TN (1) | TN2014000518A1 (fr) |
WO (1) | WO2013188673A2 (fr) |
ZA (1) | ZA201409124B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11053509B2 (en) | 2016-04-19 | 2021-07-06 | Csir | Plant-produced chimaeric Orbivirus VLPs |
WO2017187131A1 (fr) * | 2016-04-26 | 2017-11-02 | London School Of Hygiene & Tropical Medicine | Vaccin contre des reoviridae |
CN110049994B (zh) * | 2016-12-08 | 2023-05-02 | 拜西欧斯(北京)生物技术有限公司 | 一种缀合物及其应用 |
CN109897092B (zh) * | 2019-04-02 | 2019-11-19 | 深圳海关动植物检验检疫技术中心 | 一种蓝舌病病毒非结构蛋白ns3的可溶制备方法 |
CN110016466B (zh) * | 2019-05-21 | 2022-09-13 | 云南省畜牧兽医科学院 | 特异性检测蓝舌病病毒的单抗及其杂交瘤细胞株和应用 |
CN110257560B (zh) * | 2019-07-23 | 2023-06-27 | 深圳海关动植物检验检疫技术中心 | 一种用于蓝舌病病毒8型检测的试剂、检测方法及应用 |
CN112375848A (zh) * | 2020-12-11 | 2021-02-19 | 云南省畜牧兽医科学院 | 一种蓝舌病病毒血清型鉴定的RT-qPCR检测试剂盒和方法 |
CN117363588A (zh) * | 2023-02-15 | 2024-01-09 | 中国农业科学院兰州兽医研究所 | 一种表达四半胱氨酸标签重组蓝舌病毒的制备方法及应用 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
US4708871A (en) | 1983-03-08 | 1987-11-24 | Commonwealth Serum Laboratories Commission | Antigenically active amino acid sequences |
DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
US4963481A (en) | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
DE3730599A1 (de) | 1986-09-12 | 1988-07-07 | Genentech Inc | Verfahren zur kontinuierlichen herstellung von heterologen proteinen in eukaryontischen wirtszellen |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
EP0575491B1 (fr) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Souche de vaccin mise au point par genie genetique |
EP0826063A1 (fr) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Formulations en ampoule unidose de complexes adn/lipides |
US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
FR2751225B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
FR2751227B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
FR2751229B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins |
FR2751228B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Vaccin polynucleotidique bovin pour voie intradermique |
ATE292980T1 (de) | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
DE69826124T3 (de) | 1997-06-30 | 2007-10-11 | Institut Gustave Roussy | Verabreichung der nukleinsäure in den quergestreiften muskel |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
FR2801607B1 (fr) | 1999-11-26 | 2001-12-28 | Merial Sas | Pneumovirus du canard et vaccins correspondants |
US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
EP1651265B1 (fr) | 2003-07-24 | 2008-04-23 | Merial Limited | Formulation vaccinale comportant une émulsion d'huile en eau |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
EP2062594A1 (fr) * | 2007-11-21 | 2009-05-27 | Wyeth Farma, S.A. | Vaccin de la fièvre catarrhale du mouton et compositions immunogènes, procédé d'utilisation et son procédé de production |
EP3037526B1 (fr) * | 2007-11-26 | 2018-03-14 | London School of Hygiene and Tropical Medicine | Procédé de fabrication d'une souche virale vaccinale d'un virus de la famille des reoviridae |
-
2013
- 2013-06-13 ES ES13766730.9T patent/ES2664069T3/es active Active
- 2013-06-13 BR BR112014031133-1A patent/BR112014031133B1/pt active IP Right Grant
- 2013-06-13 RU RU2015100269A patent/RU2656187C2/ru active
- 2013-06-13 KR KR1020157000827A patent/KR102136437B1/ko active IP Right Grant
- 2013-06-13 NZ NZ703297A patent/NZ703297A/en unknown
- 2013-06-13 AU AU2013274191A patent/AU2013274191B2/en active Active
- 2013-06-13 CN CN201380038286.6A patent/CN104582724A/zh active Pending
- 2013-06-13 MA MA37749A patent/MA37749B1/fr unknown
- 2013-06-13 EP EP13766730.9A patent/EP2861248B1/fr active Active
- 2013-06-13 CN CN201910804847.8A patent/CN110628822A/zh active Pending
- 2013-06-13 MX MX2014015311A patent/MX364875B/es active IP Right Grant
- 2013-06-13 US US13/917,259 patent/US10801039B2/en active Active
- 2013-06-13 CA CA2876196A patent/CA2876196C/fr active Active
- 2013-06-13 WO PCT/US2013/045667 patent/WO2013188673A2/fr active Application Filing
- 2013-06-13 JP JP2015517428A patent/JP6347257B2/ja active Active
-
2014
- 2014-12-09 IL IL236148A patent/IL236148B/en active IP Right Grant
- 2014-12-11 ZA ZA2014/09124A patent/ZA201409124B/en unknown
- 2014-12-12 TN TN2014000518A patent/TN2014000518A1/fr unknown
-
2015
- 2015-10-14 HK HK15110020.6A patent/HK1209326A1/xx unknown
-
2016
- 2016-10-03 AU AU2016235036A patent/AU2016235036A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20130337010A1 (en) | 2013-12-19 |
IL236148A0 (en) | 2015-01-29 |
AU2016235036A1 (en) | 2016-10-27 |
CA2876196C (fr) | 2021-09-21 |
KR20150036057A (ko) | 2015-04-07 |
EP2861248A2 (fr) | 2015-04-22 |
NZ703297A (en) | 2016-04-29 |
ES2664069T3 (es) | 2018-04-18 |
IL236148B (en) | 2019-05-30 |
MA37749A1 (fr) | 2016-08-31 |
BR112014031133A2 (fr) | 2017-08-15 |
US10801039B2 (en) | 2020-10-13 |
CN110628822A (zh) | 2019-12-31 |
TN2014000518A1 (en) | 2016-03-30 |
KR102136437B1 (ko) | 2020-07-21 |
RU2015100269A (ru) | 2016-08-10 |
BR112014031133B1 (pt) | 2023-02-07 |
RU2656187C2 (ru) | 2018-05-31 |
WO2013188673A2 (fr) | 2013-12-19 |
MX2014015311A (es) | 2016-04-04 |
JP2015525076A (ja) | 2015-09-03 |
HK1209326A1 (en) | 2016-04-01 |
ZA201409124B (en) | 2017-05-31 |
JP6347257B2 (ja) | 2018-06-27 |
AU2013274191B2 (en) | 2016-09-22 |
AU2013274191A1 (en) | 2015-01-22 |
EP2861248B1 (fr) | 2017-11-15 |
CA2876196A1 (fr) | 2013-12-19 |
WO2013188673A3 (fr) | 2014-03-27 |
MX364875B (es) | 2019-05-09 |
CN104582724A (zh) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA37749B1 (fr) | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine | |
MX2017001406A (es) | Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva. | |
EA201591287A1 (ru) | Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения | |
GB0917002D0 (en) | Improved shigella blebs | |
EA201391109A1 (ru) | Молекулы нуклеиновой кислоты, кодирующие новые антигены герпеса, вакцина, включающая их, и способы их использования | |
MX2014009289A (es) | Anticuerpos c1orf32 y usos de los mismos para el tratamiento del cancer. | |
MX2019007921A (es) | Nuevos agentes de union a ha. | |
IN2014CN00688A (fr) | ||
MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
WO2013106834A3 (fr) | Peptides wt-1 immunogènes et leurs procédés d'utilisation | |
EA201001491A1 (ru) | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов | |
EA201290876A1 (ru) | Композиции индуцированных дендритных клеток и их использование | |
EA201391240A1 (ru) | Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza | |
TR201905619T4 (tr) | Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri. | |
EA201500383A1 (ru) | Производные 1,2,4-триазина для лечения вирусных инфекций | |
EA201391515A1 (ru) | Инактивированная вакцина вируса денге | |
GB201017519D0 (en) | Vaccines | |
NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
MX366178B (es) | Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos. | |
WO2013177593A3 (fr) | Identification d'antigènes phosphopeptidiques de cmh de classe i du cancer du sein à l'aide d'une technologie shla et de stratégies d'enrichissement complémentaires | |
PH12017501100A1 (en) | Recombinant swinepox virus and vaccines | |
MX363149B (es) | Vacunas de nucleoproteina de la influenza. | |
MX2019007924A (es) | Vacunas contra la influenza. | |
TR201911128T4 (tr) | Neısserıa menıngıtıdıs fhbp varyantı ve bunun aşılamaya yönelik kullanımı. | |
MX2014009022A (es) | Virus de influenza c y vacuna. |